Sentinel lymph node biopsy using dye alone in patients with initially cN1 breast cancer and ycN0 status after neoadjuvant therapy: a multicenter diagnostic trial
机构：[1]China Med Univ, Hosp 1, Shenyang, Peoples R China[2]Dalian Univ, Dept Thyroid & Breast Surg, Zhongshan Hosp, Dalian, Peoples R China[3]Harbin Med Univ, Dept Gen Surg, Affiliated Hosp 2, Harbin, Peoples R China[4]China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Breast Surg, Shenyang, Peoples R China[5]Hebei Med Univ, Breast Ctr, Hosp 4, Shijiazhuang, Peoples R China临床科室外一科河北医科大学第四医院[6]Zhejiang Univ, Dept Breast Surg, Affiliated Hosp 1, Hangzhou, Peoples R China浙江大学医学院附属第一医院[7]Dalian Med Univ, Inst Breast Dis, Dept Breast Surg, Hosp 2, Dalian, Peoples R China[8]Kunming Med Univ, Tumor Hosp Yunnan, Affiliated Hosp 3, Dept Breast Surg, Kunming, Peoples R China
Background Given the known complications associated with axillary lymph node dissection (ALND) and the limited
application of radiolabeled colloid tracking in China, dye-only sentinel lymph node biopsy (SLNB) is proposed as a
feasible and alternative surgical treatment strategy for patients with initially clinically node-positive (cN1) breast
cancer to a clinically node-negative (ycN0) status after neoadjuvant therapy (NAT). However, the clinical diagnostic
performance of dye-only SLNB needs further verification.
基金：
Tackling Key Problems and Serving Local Projects of Liaoning Province
(ZF20190006, to BC), National Natural Science Foundation of China (82073282 and 82203873, to AZ) and Joint Fund
Project of the Science and Technology Program of Liaoning Province (2023012141-JH3/4600, to AZ).
语种：
外文
WOS：
中科院分区：
出版当年[2025]版：
大类|1 区医学
小类|1 区卫生保健与服务1 区公共卫生、环境卫生与职业卫生
最新[2025]版：
大类|1 区医学
小类|1 区卫生保健与服务1 区公共卫生、环境卫生与职业卫生
JCR分区：
出版当年[2024]版：
Q1HEALTH CARE SCIENCES & SERVICESQ1PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
最新[2024]版：
Q1HEALTH CARE SCIENCES & SERVICESQ1PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
第一作者机构：[1]China Med Univ, Hosp 1, Shenyang, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Zheng Ang,Zhang Lei,Cao Yu,et al.Sentinel lymph node biopsy using dye alone in patients with initially cN1 breast cancer and ycN0 status after neoadjuvant therapy: a multicenter diagnostic trial[J].LANCET REGIONAL HEALTH-WESTERN PACIFIC.2025,55:doi:10.1016/j.lanwpc.2024.101315.
APA：
Zheng, Ang,Zhang, Lei,Cao, Yu,Zhang, Dian-Long,Ma, Fei...&Chen, Bo.(2025).Sentinel lymph node biopsy using dye alone in patients with initially cN1 breast cancer and ycN0 status after neoadjuvant therapy: a multicenter diagnostic trial.LANCET REGIONAL HEALTH-WESTERN PACIFIC,55,
MLA：
Zheng, Ang,et al."Sentinel lymph node biopsy using dye alone in patients with initially cN1 breast cancer and ycN0 status after neoadjuvant therapy: a multicenter diagnostic trial".LANCET REGIONAL HEALTH-WESTERN PACIFIC 55.(2025)
医学